The Bid & Ask

Quotations, Dispatches, and the Daily Tape

Friday, August 14, 2026

Subject of the day

A

Concerning the House

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

United States · www.agilent.com

The Long Run

FY 2009–2025 · 17 years

LineLatestCAGRTrend
Revenue$6.95B+2.8%
Operating income$1.35B+23.4%
Net income$1.29B+0.9%
Cash from ops$1.75B+3.8%
Quotation

$149.29

+1.05 (+0.7%)

52w hi$156.26
52w lo$109.78
Vol756.67K
As ofAug 13
The Verdict

Hold

Our score +0.27

Short+0.03
Medium+0.39
Long+0.51

computed 2026-08-13

By the Numbers

Agilent Technologies, Inc.

Healthcare · Diagnostics & Research

Market cap$42.16B
Enterprise value$43.60B
Trailing P/E29.98x
Forward P/E22.58x
EV / EBITDA21.64x
P / S (ttm)5.83x
Profit margin19.6%
Return on equity21.3%
Revenue growth+10.0%
Earnings growth+60.0%
Debt / equity49.73
Risk Metrics
Beta vs SPX0.97
Corr SPX0.50
Annual vol31.5%
Annual ret+9.2%
Sharpe0.29
Max DD-34.9%

Window: 504 trading days (504 obs)

Layer Breakdown
LayerRawContribution
Fundamental+0.31
Sector+0.12
Technical+0.09
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-08-13

Recent Sessions
DateOpenHighLowCloseVol
Aug 13$149.00$149.58$146.82$149.29756.67K
Aug 12$148.94$149.33$147.33$148.241.37M
Aug 11$147.69$150.24$147.40$149.491.20M
Aug 10$146.26$148.82$145.45$148.721.75M
Aug 7$141.43$146.16$140.85$145.971.53M